It is not clear exactly how the GYPB-A fusion protein confers protection against malaria, but it has been suggested that it could affect interactions with Plasmodium falciparum receptors and host band 3 protein at the erythrocyte surface.5 The gene discussed is GYPB; the disease is malaria.